Abbott Laboratories (ABT)
115.06
-0.68
(-0.59%)
USD |
NYSE |
Nov 14, 16:00
115.06
0.00 (0.00%)
After-Hours: 17:42
Abbott Laboratories Research and Development Expense (Quarterly): 713.00M for Sept. 30, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 713.00M |
| June 30, 2024 | 698.00M |
| March 31, 2024 | 684.00M |
| December 31, 2023 | 700.00M |
| September 30, 2023 | 672.00M |
| June 30, 2023 | 715.00M |
| March 31, 2023 | 654.00M |
| December 31, 2022 | 725.00M |
| September 30, 2022 | 782.00M |
| June 30, 2022 | 684.00M |
| March 31, 2022 | 697.00M |
| December 31, 2021 | 762.00M |
| September 30, 2021 | 672.00M |
| June 30, 2021 | 654.00M |
| March 31, 2021 | 654.00M |
| December 31, 2020 | 698.00M |
| September 30, 2020 | 580.00M |
| June 30, 2020 | 564.00M |
| March 31, 2020 | 578.00M |
| December 31, 2019 | 595.00M |
| September 30, 2019 | 596.00M |
| June 30, 2019 | 577.00M |
| March 31, 2019 | 672.00M |
| December 31, 2018 | 562.00M |
| September 30, 2018 | 574.00M |
| Date | Value |
|---|---|
| June 30, 2018 | 575.00M |
| March 31, 2018 | 589.00M |
| December 31, 2017 | 619.00M |
| September 30, 2017 | 568.00M |
| June 30, 2017 | 520.00M |
| March 31, 2017 | 553.00M |
| December 31, 2016 | 368.00M |
| September 30, 2016 | 352.00M |
| June 30, 2016 | 348.00M |
| March 31, 2016 | 379.00M |
| December 31, 2015 | 369.00M |
| September 30, 2015 | 378.00M |
| June 30, 2015 | 345.00M |
| March 31, 2015 | 313.00M |
| December 31, 2014 | 361.00M |
| September 30, 2014 | 305.00M |
| June 30, 2014 | 310.00M |
| March 31, 2014 | 369.00M |
| December 31, 2013 | 359.00M |
| September 30, 2013 | 339.00M |
| June 30, 2013 | 363.00M |
| March 31, 2013 | 346.00M |
| December 31, 2012 | 377.03M |
| September 30, 2012 | 350.65M |
| June 30, 2012 | 370.60M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
564.00M
Minimum
Jun 2020
782.00M
Maximum
Sep 2022
674.05M
Average
684.00M
Median
Jun 2022
Research and Development Expense (Quarterly) Benchmarks
| Boston Scientific Corp | 407.00M |
| Becton Dickinson & Co | 302.00M |
| ResMed Inc | 79.52M |
| Globus Medical Inc | 35.38M |
| Insulet Corp | 54.90M |